SEC Tracker
Get the app

Bausch Health Companies BHC

Bausch Health reports Q3 2026 results

Item 2.02 Reports results

Form
8-K
Filed
Importance
Major
  1. Financial results for quarter ended September 30, 2026
  2. Exhibit 99.1 includes press release

Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Bausch Health Companies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Recursion Pharmaceuticals RXRX public float $2.0B, Jun 30, 2025
  2. Agios Pharmaceuticals AGIO public float $1.9B, Jun 30, 2025
  3. Vericel VCEL public float $2.1B, Jun 30, 2025
  4. Biocryst Pharmaceuticals BCRX public float $1.9B, Jun 30, 2025
  5. Indivior Pharmaceuticals INDV public float $1.8B, Jun 30, 2025